Screening for type 2 diabetes in obese youth

Pediatrics

Volumn 124, Issue 2, 2009, Pages 573-579

  Shah, Shuchi ^a   Kublaoui, Bassil M ^a   Oden, Jon D ^a   White, Perrin C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

1; 5 anhydroglucitol; Fasting blood glucose; Hemoglobin A1c; HOMA IR; Oral glucose tolerance test; Receiver operator characteristic analysis

Indexed keywords

1,5 ANHYDROSORBITOL; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD EXAMINATION; CHILD; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MASS SCREENING; OBESITY; PREDICTIVE VALUE OF TESTS; ROC CURVE; TEXAS;

EID: 67749147169     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2949     Document Type: Article

References (24)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555
2. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884-1890
3. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23(3):381-389
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007 [published correction appears in Diabetes Care. 2008;31(6):1271]. Diabetes Care. 2008;31(3):596-615
5. Rhodes ET, Finkelstein JA, Marshall R, Allen C, Gillman MW, Ludwig DS. Screening for type 2 diabetes mellitus in children and adolescents: attitudes, barriers, and practices among pediatric clinicians. Ambul Pediatr. 2006;6(2):110-114
6. Marrero DG, Vandagriff JL, Gibson R, et al. Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population. Diabetes Care. 1992;15(8):1045-1049
7. Nowatzke W, Sarno MJ, Birch NC, Stickle DF, Eden T, Cole TG. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer. Clin Chim Acta. 2004;350(1-2):201-9
8. Eng J. ROC Analysis: Web-Based Calculator for ROC Curves.1.0.2 ed. Baltimore, MD: Johns Hopkins University; 2006
9. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res. 2005;2(1):9-15
10. Greenberg RA, Sacks DB. Screening for diabetes: is it warranted? Clin Chim Acta. 2002;315(1-2):61-69
11. Sainaghi PP, Castello L, Limoncini AM, Bergamasco L, Bartoli E, Schianca GP. Poor specificity of fasting plasma glucose cut-off values in ruling out glucose intolerance: the complementary usefulness of OGTT. Exp Clin Endocrinol Diabetes. 2007;115(2):112-117
12. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753-759
13. Tsukui S, Kobayashi I. Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus. Diabet Med. 1995;12(10):899-903
14. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care. 2000;23(2):187-191
15. American Diabetes Association. Standards of medical care in diabetes: 2008. Diabetes Care. 2008;31(suppl 1):S12-S54
16. Nichols GA, Arondekar B, Herman WH. Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care. 2008;46(3):287-292
17. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe. Lancet. 1999;354(9179):617-621
18. Jones LH, Ficca M. Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes? J Sch Nurs. 2007;23(5):247-251
19. Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health. 2001;28(5):372-376
20. Centers for Disease Control and Prevention. CDC statement on screening children for acanthosis nigricans in schools and communities. Available at: www.cdc.gov/diabetes/news/docs/an.htm. Accessed Jul 1, 2008
21. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346(11):802-810
22. McGill JB, Cole TG, Nowatzke W, et al. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care. 2004;27(8):1859-1865
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-S20
24. Obuchowski NA. An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale. Stat Med. 2006;25(3):481-493